These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22246677)

  • 1. Affinity-based proteomic profiling: problems and achievements.
    Medvedev A; Kopylov A; Buneeva O; Zgoda V; Archakov A
    Proteomics; 2012 Feb; 12(4-5):621-37. PubMed ID: 22246677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of immobilized metal affinity chromatography in proteomics.
    Sun X; Chiu JF; He QY
    Expert Rev Proteomics; 2005 Oct; 2(5):649-57. PubMed ID: 16209645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity chromatography: a useful tool in proteomics studies.
    Azarkan M; Huet J; Baeyens-Volant D; Looze Y; Vandenbussche G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):81-90. PubMed ID: 17113368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of ligand based models for protein domains to predict novel molecular targets and applications to triage affinity chromatography data.
    Bender A; Mikhailov D; Glick M; Scheiber J; Davies JW; Cleaver S; Marshall S; Tallarico JA; Harrington E; Cornella-Taracido I; Jenkins JL
    J Proteome Res; 2009 May; 8(5):2575-85. PubMed ID: 19271732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionation of proteins by immobilized metal affinity chromatography.
    Sun X; Chiu JF; He QY
    Methods Mol Biol; 2008; 424():205-12. PubMed ID: 18369864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-fractionation of rat liver cytosol proteins prior to mass spectrometry-based proteomic analysis using tandem biomimetic affinity chromatography.
    Tan Q; Dong D; Ye L; Huo C; Huang F; Li R
    J Mol Recognit; 2010; 23(1):93-100. PubMed ID: 19862701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemistry-based functional proteomics for drug target deconvolution.
    Wang K; Yang T; Wu Q; Zhao X; Nice EC; Huang C
    Expert Rev Proteomics; 2012 Jun; 9(3):293-310. PubMed ID: 22809208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity prefractionation for MS-based plasma proteomics.
    Pernemalm M; Lewensohn R; Lehtiö J
    Proteomics; 2009 Mar; 9(6):1420-7. PubMed ID: 19235168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel fractionation method prior to MS-based proteomics analysis using cascade biomimetic affinity chromatography.
    Tan Q; Dong D; Li R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(30):3799-805. PubMed ID: 19815467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid-phase-based separation systems for depletion, prefractionation and enrichment of proteins in biological fluids for in-depth proteomics analysis.
    Jmeian Y; El Rassi Z
    Electrophoresis; 2009 Jan; 30(1):249-61. PubMed ID: 19101934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enrichment of phosphoproteins for proteomic analysis using immobilized Fe(III)-affinity adsorption chromatography.
    Guerrera IC; Predic-Atkinson J; Kleiner O; Soskic V; Godovac-Zimmermann J
    J Proteome Res; 2005; 4(5):1545-53. PubMed ID: 16212405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging protein purification strategies in proteomics.
    Roy I; Mondal K; Gupta MN
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):32-42. PubMed ID: 17141589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical proteomics for drug discovery based on compound-immobilized affinity chromatography.
    Katayama H; Oda Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):21-7. PubMed ID: 17241823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug target deconvolution by chemical proteomics.
    Raida M
    Curr Opin Chem Biol; 2011 Aug; 15(4):570-5. PubMed ID: 21763176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two step fractionation approach for plasma proteomics using immunodepletion of abundant proteins and multi-lectin affinity chromatography: Application to the analysis of obesity, diabetes, and hypertension diseases.
    Dayarathna MK; Hancock WS; Hincapie M
    J Sep Sci; 2008 Apr; 31(6-7):1156-66. PubMed ID: 18306431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances and applications of de novo designed affinity ligands in proteomics.
    Roque AC; Lowe CR
    Biotechnol Adv; 2006; 24(1):17-26. PubMed ID: 16006085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of phosphorylated proteins.
    Turkina MV; Vener AV
    Methods Mol Biol; 2007; 355():305-16. PubMed ID: 17093319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immobilized-metal affinity chromatography (IMAC): a review.
    Block H; Maertens B; Spriestersbach A; Brinker N; Kubicek J; Fabis R; Labahn J; Schäfer F
    Methods Enzymol; 2009; 463():439-73. PubMed ID: 19892187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity profiling of platelets by chemical proteomics.
    Wong JW; McRedmond JP; Cagney G
    Proteomics; 2009 Jan; 9(1):40-50. PubMed ID: 19053083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic methods for drug target discovery.
    Sleno L; Emili A
    Curr Opin Chem Biol; 2008 Feb; 12(1):46-54. PubMed ID: 18282485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.